Search Results
Found 328 results for static/resources/js/signals.min.js.
Vaccine Development
PPD has worked in vaccine development for more than 30 years, offering full-service capabilities.
The Top Seven Things to Understand About Data Monitoring Committees
In this blog post, PPD experts discuss best practices that can be applied to data monitoring committees (DMCs).
Using Technology to Overcome Resourcing Challenges
Learn how technology can help pharma and biopharma companies gain efficiency in capacity management and resourcing.
How PPD’s New Implementation Lead Role Streamlines Onboarding Efficiency for FSP Projects
Learn how the implementation lead role helps better manage the early complexities of FSP projects to enable seamless project onboarding.
Clinical Trial Biostatistics
In the past five years, a team of nearly 900 dedicated biostatistics and programming staff from the PPD clinical research business of Thermo Fisher Scientific has supported nearly 1,200 studies spanning every phase of clinical trials.
Rare Disease CRO Services
PPD is deeply committed to advancing rare disease CRO research. Find out more about our patient-centric solutions that reach globally dispersed populations.
REMS: To Outsource or Not to Outsource?
Implementing and managing a REMS program requires specific skills and expertise. Explore the pros and cons of outsourcing a REMS program.
Three Key Pillars for a Bespoke Recruitment Strategy for FSP Partnerships
Skilled recruiters and a phased talent delivery approach are customizing and accelerating functional service provider (FSP) partnerships.
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organization, today announced a collaboration to help bring clinical research to historically underserved patient populations through NMQF’s Alliance for Representative Clinical Trials (ARC).